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Abstract
Human induced pluripotent stem cells (hiPSCs) possess the capabilities of self-renewal and differentiation into multiple cell
types, and they are free of the ethical problems associated with human embryonic stem cells (hESCs). These characteristics
make hiPSCs a promising choice for future regenerative medicine research. There are significant obstacles, however,
preventing the clinical use of hiPSCs. One of the most obvious safety issues is the presence of residual undifferentiated cells
that have tumorigenic potential. To locate residual undifferentiated cells, in vivo teratoma formation assays have been
performed with immunodeficient animals, which is both costly and time-consuming. Here, we examined three in vitro assay
methods to detect undifferentiated cells (designated an in vitro tumorigenicity assay): soft agar colony formation assay, flow
cytometry assay and quantitative real-time polymerase chain reaction assay (qRT-PCR). Although the soft agar colony
formation assay was unable to detect hiPSCs even in the presence of a ROCK inhibitor that permits survival of dissociated
hiPSCs/hESCs, the flow cytometry assay using anti-TRA-1-60 antibody detected 0.1% undifferentiated hiPSCs that were
spiked in primary retinal pigment epithelial (RPE) cells. Moreover, qRT-PCR with a specific probe and primers was found to
detect a trace amount of Lin28 mRNA, which is equivalent to that present in a mixture of a single hiPSC and 5.0610
4 RPE
cells. Our findings provide highly sensitive and quantitative in vitro assays essential for facilitating safety profiling of hiPSC-
derived products for future regenerative medicine research.
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Introduction
Pluripotent stem cells such as embryonic stem cells and induced
pluripotent stem cells have two capabilities: 1) pluripotency: the
ability to differentiate into a variety of cells and 2) self-renewal: the
ability to undergo numerous cycles of cell division while
maintaining their cellular identity. Because of these two charac-
teristics, it has been expected that they would provide new sources
for robust and continuous production of a variety of cells and
tissues for regenerative medicine/cell therapy. Additionally,
hiPSCs offer us a possible solution to the ethical problems and
the immune rejection of hESC-derived cells, thus raising novel
avenues for patient-specific cell therapy. As previously reported
[1,2], many attempts are currently underway to differentiate
hESCs and hiPSCs into various tissues: cardiomyocytes [2,3],
neurons [2,4], and hepatocytes [5,6]. It is noteworthy that clinical
trials have been conducted with retinal pigment epithelial (RPE)
cells derived from hESCs to treat patients with dry age-related
macular degeneration and Stargardt’s macular dystrophy by
Advanced Cell Technology. hiPSCs have also been shown to
differentiate into RPE cells, which display functionality both in vitro
and in vivo [7,8]. Thus, autologous transplant of hiPSC-derived
RPE cells holds great promise in the clinical therapy of macular
degeneration.
Although hiPSCs overcome immunogenic and ethical barriers,
the translation of hiPSCs into the clinical setting faces the same
significant problems as those of hESCs. One of the most important
issues in the development of a safe pharmaceutical or medical
device derived from human pluripotent stem cells is ensuring that
the final product does not form tumors after implantation [9].
There are two primary concerns. First, the cell-based product may
be unstable and transform to produce a tumor, which is a common
problem for any cell-based products, regardless of the cell types of
the raw materials. Second, the product derived from human
pluripotent stem cells might contain residual undifferentiated stem
cells that would eventually proliferate and form a teratoma [10].
Previous reports have shown that several hundred hESCs were
sufficient for generating tumors in immunodeficient mice [11,12].
Hence, to adress the second concern above, it is critical to develop
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stem cells in the final products, and to determine their lower limit
of detection (LLOD). An evaluation study of the in vivo
tumorigenicity assay using severe combined immunodeficiency
(SCID) mice has shown that 245 undifferentiated hESCs spiked
into 10
6 feeder fibroblasts produce a teratoma [11]. On the other
hand, some in vitro assays, such as quantitative real-time
polymerase chain reaction (qRT-PCR), flow cytometry and
immunohistochemistry, have been used to indicate the undiffer-
entiated state of stem cells with various markers (such as Oct-3/4,
Nanog, Sox2, TRA-1-60, TRA-1-81, SSEA-3 and SSEA-4) [13–
15]. However, it has not been determined how many residual
undifferentiated hiPSCs can be detected by these in vitro assays.
In this study, to establish a high sensitivity assay for detection of
residual undifferentiated hiPSCs in the final product, we evaluated
three in vitro assays: soft agar colony formation assay, flow
cytometry and qRT-PCR. To achieve this goal, these assays were
used on cell mixtures that contained defined numbers of
undifferentiated hiPSCs in primary RPE cells, and we also tried
to determine the LLOD of each assay by using multiple lots of
primary RPE cells as backgrounds. Through this process, we
revealed that one-step qRT-PCR using probes and primers
targeting Lin28 transcripts can detect levels as low as 0.002%
residual undifferentiated cells in hiPSC-derived RPE cells.
Results
In vitro differentiation of hiPSCs into retinal pigment
epithelial cells
Minimizing contamination of undifferentiated pluripotent stem
cells in cell therapy products is crucial because of the risk of
tumorigenesis. To evaluate residual undifferentiated hiPSCs in
differentiated cells, it is necessary to determine the LLOD of the
hiPSC content in RPE cells. First, we differentiated hiPSCs into
RPE cells using the in vitro differentiation protocol previously
described (Fig. 1A) [7]. The hiPSC-derived RPE cells exhibited
polygonal, cobblestone-like morphology, an indication of RPE
maturation, which is similar to that of the primary RPE cells
(Fig. 1B). Immunocytochemical staining revealed that N-cadherin,
the major cadherin expressed in RPE cells [16], showed a
distribution to the tight junction of the hiPSC-derived RPE cells,
which is consistent with primary RPE cells (Fig. 1C). Moreover, in
flow cytometry experiments, a strong expression of the visual cycle
protein CRALBP and the melanosomal matrix protein GP-100
was detected in both primary RPE and hiPSC-derived RPE cells
compared to in undifferentiated hiPSCs (Fig. 1D). To characterize
developmental stages during RPE differentiation, a qRT-PCR
assay was used to identify transcript levels of CRALBP and the
visual cycle protein RPE65, indicating that CRALBP and RPE65
increased as differentiation progresses and were equally well
expressed both in the mature hiPSC-derived RPE cells and
primary RPE cells (Fig. 1E). Together, these data showed that
mature RPE cells differentiated from hiPSCs possess similar
properties to primary RPE cells.
Soft agar colony formation assay of hiPSCs
The soft agar colony formation assay is a general method to
monitor anchorage-independent growth, which is considered the
most appropriate in vitro assay for detecting the malignant
transformation of cells [17]. To measure cell transformation
quantitatively, we used the CytoSelect 96-well Cell Transforma-
tion Assay, as described in the Materials and Methods section.
Previous reports have shown that human pluripotent stem cells
undergo apoptosis when dissociated into single cells [18].
However, preparation of single cell suspension is quite important
because the presence of cell clumps or adjacent cells is critical for
growth in an agar medium. Thus, we first sought to clarify
whether single hiPSCs grow in the soft agar medium. The soft agar
colony formation assay showed that single-hiPSCs could not
proliferate in the agar medium. In addition, the ROCK inhibitor
Y-27632, which has been reported to inhibit apoptosis [19], did
not improve survival of hiPSCs under our conditions (Fig. 2A and
S1A). These results demonstrated that the soft agar colony
formation assay is not appropriate for detection of undifferentiated
hiPSCs in single cell suspension.
Next, we tested whether colony formation of the human ovarian
teratocarcinoma cell line PA-1 [20] occurs in an agar medium,
since PA-1 cells could mimic possible malignant cells derived from
hiPSC. PA-1 cells efficiently formed colonies in soft agar
depending on the number of cells (Fig. S1B). On the other hand,
primary RPE cells did not grow in a soft agar media with 1.0610
4
cells/well, even when cultured for 30 days (Fig. S1C). Based on
these results, we aimed to examine the sensitivity of the soft agar
colony formation assay to detect PA-1 cells. We spiked 100 (1%),
50 (0.5%), and 25 (0.25%) PA-1 cells into 1610
4 primary RPE
cells in order to define the minimum number of PA-1 cells
required to grow in a soft agar media. The largest number of PA-1
cells (1%) gave rise to detectable colonies within 20 days, whereas
lesser numbers of PA-1 cells (0.5% and 0.25%) required 30 days
until the colonies become detectable (Fig. 2A and B). We next tried
to determine the LLOD of the soft agar colony formation assay.
The LLOD of the assay signal was calculated as the mean plus 3.3
fold the standard deviation of the measurement of negative
controls [21]. Based on signals from three lots of primary RPE
cells as a negative control (1.7160.40 [fold over the background
signal]), the LLOD of the soft agar transformation assay was
calculated as 3.03 (Fig. 2C). These results indicate that at least 1%
spiked PA-1 cells are necessary for detecting colonies in primary
RPE cells using the soft agar transformation assay (4.461.1). As
shown in Fig. 2C, the hiPSC-derived RPE cells showed no colony
formation in the soft agar medium, and the assay signal was lower
than the LLOD (1.2160.19). These results suggest that the
contamination of transformed cells, assuming that their anchorage
independency is comparable to PA-1, is less than 1% in the
hiPSC-derived RPE cells.
Detection of undifferentiated hiPSCs by flow cytometry
In the second set of the experiments, we tried to detect residual
undifferentiated cells via flow cytometry. Using five antibodies
which recognize stem cell marker antigens (Oct3/4, Nanog, Sox2,
TRA-1-60, TRA-1-81), we first attempted to identify highly
selective markers that distinguish a small population of hiPSCs
from primary RPE cells. To minimize nonspecific staining, we
used fluorescent conjugated monoclonal antibodies for the flow
cytometry. All of the stem cell markers were detected in
undifferentiated hiPSCs, but the levels of cell staining differed
between the antibodies, presumably attributable to the protein
expression in the cells and/or the avidity of the antibodies. The
fluorescence histograms of hiPSCs and primary RPE cells showed
that anti-Oct3/4, anti-Sox2 and anti-TRA-1-60 antibodies clearly
distinguished hiPSCs from RPE cells (Fig. 3A). Because TRA1-60
is not only a marker of undifferentiated hiPSCs but also of
embryonal carcinoma [22], we employed anti-TRA-1-60 antibody
in further experiments. The TRA-1-60
+ gate was defined as
including at most 0.05% of the primary RPE cells with the highest
fluorescence (Fig. 3B). In the flow cytometry, the mean and
standard deviation of TRA-1-60
+ cells in the primary RPE cells
(the negative controls) were 26.6 and 15.6 cells/10
5 cells,
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5 cells (Fig. 3B).
To analyze the performance of the system for detection of residual
hiPSCs, we spiked 2.5610
3 (0.1%) and 2.5610
2 (0.01%) hiPSCs
into 2.5610
6 primary RPE cells and analyzed 1.0610
5 cells via
flow cytometry using anti-TRA-1-60 antibody. We also confirmed
the number of the applied hiPSCs by spiking CFDA-stained
hiPSCs (Fig. S2). In the experiment shown in Fig. 3C, 130 and 19
cells were identified as TRA-1-60
+ cells in 0.1% and 0.01%
hiPSCs spiked samples, respectively. These results indicated that at
least 0.1% of residual undifferentiated hiPSCs (2.5610
3 cells out of
2.5610
6 cells) can be detected via the flow cytomerty. Finally, to
detect residual undifferentiated cells in hiPSC-derived RPE cells,
we tested 1610
5 cells and detected six TRA-1-60
+ cells, suggesting
that the population of undifferentiated hiPSCs in the hiPSC-
derived RPE cells was no more than 0.1% (Fig. 3D).
Detection of undifferentiated hiPSCs via qRT-PCR
We next tested the ability of qRT-PCRs to detect a trace
amount of stem cell-specific mRNA. To identify highly selective
markers for undifferentiated hiPSCs, we compared the mRNA
levels of OCT3/4, KLF4, c-MYC, SOX2, NANOG, LIN28 and
REX1 in hiPSCs and primary RPE cells (Fig. 4A). Primary RPE
cells were found to endogenously express c-Myc at 25.49% of the
levels observed in hiPSC, which was consistent with the previous
finding that MEF expressed c-Myc at approximately 20% of levels
observed in mouse ES cells [23]. The expression levels of Klf4 and
Rex1 in primary RPE cells were 3.51% and 2.23% compared with
hiPSCs, respectively. On the other hand, more than a 1000-fold
difference between primary RPE cells and hiPSCs was observed in
the gene expression of Nanog (0.07%), Sox2 (0.06%), Oct3/4
(0.01%) and Lin28 (not detected). These results suggested that the
latter four genes are useful in detecting hiPSCs in RPE cells.
We then conducted two sets of qRT-PCR assays to evaluate the
utility of these marker genes to detect spiked hiPSCs in primary
RPE cells. We first measured mRNA levels of Nanog, Oct3/4 and
Lin28 in the five lots of primary RPE cells (the negative control) to
determine the LLOD. The LLODs for Nanog and Oct3/4
mRNAs were 0.45% and 0.04% those of hiPSCs, respectively
(Fig. 4B). The LLOD of Lin28 could not be calculated because no
fluorescent signal for Lin28 expression was detectable in the
primary RPE cells. These results along with experiments spiking
2.5610
4 (1%), 2.5610
3 (0.1%) and 2.5610
2 (0.01%) hiPSCs into
2.5610
6 primary RPE cells (Fig. 4B) indicated that measurements
of Nanog, Oct3/4 and Lin28 expression by qRT-PCRs could
detect at least 1%, 0.1% and 0.01% contamination of residual
undifferentiated hiPSCs in RPE cells, respectively.
Finally, we examined whether qRT-PCR for Lin28 was
applicable in the detection of residual undifferentiated cells in
differentiated RPE cells from hiPSCs. Total RNA (250 ng)
extracted from the differentiating cells (day 5, 20, and 40) and
purified hiPSC-derived RPE cells (the passage number 3 and 4)
were subjected to qRT-PCR analysis. The mRNA level of Lin28
was continuously down-regulated during the differentiation
process, being 0.02% that of hiPSCs at day 40. In early passage
culture (passage number 3) after purification, Lin28 was still
significantly expressed at a level 0.002% that of hiPSCs. From
passage 4 onward, however, no detectable level of Lin28
expression was observed in hiPSC-derived RPE cells (Fig. 4C).
These results suggest that qRT-PCR analysis for Lin28 detects
0.002% of residual undifferentiated hiPSCs in hiPSC-induced
PRE cells, namely, that a single hiPSC in 5.0610
4 RPE cells is
detectable.
Discussion
For the clinical use of products derived from human pluripotent
stem cells, it is essential to improve both the efficacy and safety of
the final product. In order to develop safe hiPSC-based
treatments, the hurdle of tumorigenicity arising from undifferen-
tiated cells must be overcome [9]. To address the issue of
tumorigenicity, some recent publications have advocated the
development of protocols for the derivation of hiPSC [23–25] and
have outlined methods for the elimination of residual hESCs [26].
However, to date, more than several hundred cells are necessary
for human pluripotent stem cells to form a tumor in immuno-
compromised mice [11]. Therefore, highly sensitive tumorigenicity
assays and their standardization are necessary for detecting a small
population of residual undifferentiated cells in products derived
from human pluripotent stem cells.
In the present study, we evaluated three methods for detection
of residual undifferentiated hiPSCs in hiPSCs-derived differenti-
ated cells: soft agar colony formation assay, flow cytometry and
qRT-PCR. Table 1 summarizes the advantages and disadvantages
of the assays associated with product tumorigenicity. The soft agar
colony formation assay is known to be more sensitive in the
detection of certain types of tumorigenic cells, compared to in vivo
methods using immunocompromised mice [27]. However, we
found the soft agar colony formation assay unsuitable for detecting
residual undifferentiated hiPSCs, presumably attributable to the
dissociation-induced apoptosis of hiPSCs [18]. On the other hand,
flow cytometry and qRT-PCR assays were found to be able to
detect a trace amount of undifferentiated cells. These two assays
have been exploited for characterization of stem cell-based
products, as well as undifferentiated pluripotent stem cells, but
the present study is the first analytical and quantitative approach
designed to evaluate the detection of residual undifferentiated cells
in products derived from human pluripotent stem cells. The
advantage of the flow cytometry assay is that it is able to identify
undifferentiated cells. Unfortunately, the results are greatly
affected by gating, and only the cells expressing the marker
protein are detectable. On the other hand, the advantages of qRT-
PCR are its rapidity, quantitativity and high sensitivity, whereas its
disadvantage is that only the cells expressing the marker gene are
detectable. Although the in vivo tumorigenicity assay is costly and
time-consuming, it can directly analyze tumor formation in a
specific microenvironment where the product is implanted (eg.
retina). Therefore, a combination of relevant in vitro and in vivo
assays would be necessary to ensure the safety of a product derived
from human pluripotent stem cells. The rationale for the choice of
specific assays would be justified, based on their characteristics
shown in Table 1.
We have demonstrated that the qRT-PCR assay can success-
fully detect 0.002% residual undifferentiated hiPSCs in hiPSC-
induced RPE cells using Lin28 as a target gene (Fig. 4E). To the
best of our knowledge, this qRT-PCR assay, using solely 250 ng of
Figure 1. Differentiation of hiPSCs into retinal pigment epithelial cells. (A) Schematic diagram of the culture procedure for retinal
differentiation. Photomicrograph (B) and N-cadherin staining (C) shows that both primary RPE cells and hiPSC-derived RPE cells form polygonal,
cobblestone-like morphology. Scale bars, 100 mm. (D) Flow cytometry analysis of CRALBP and GP-100 expression in hiPSCs (red), hiPSC-derived RPE
cells (green) and primary RPE cells (blue). (E) Time-course analysis of expression of RPE cell markers, CRALBP (left) and RPE65 (right), using qRT-PCR.
Error bars represent the standard deviation of the measurements (n=3).
doi:10.1371/journal.pone.0037342.g001
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4 cells, is the most
sensitive of the previously reported methods in detecting undiffer-
entiated pluripotent stem cells. Lin28 is known to specifically
inhibit the processing of let-7 miRNAs, which are involved in cell-
fate decisions [28]. Interestingly, the aberrant expression of Lin28
transcripts has been recently reported in human germ-cell tumors
[29], suggesting that Lin28 is a useful marker of germ-cell
malignancy as well as of pluripotency of hiPSCs. Lin28 mRNA
gradually decreased in the differentiation process and was
completely diminished by passage 4 (Fig. 4C). These observations
suggest that Lin28 transcripts are also available for presenting
degree of differentiation in hiPSC-derived products because
detection of residual Lin28 confirms the contamination of
undifferentiated cells even at a late stage of differentiation.
Needless to say, the distinct expression of Lin28 could possibly
be observed in other normal somatic cells. However, Lin28 is, at
least in part, one of the potent markers for detecting incompletely
differentiated cells contained in RPE cells derived from pluripotent
stem cells.
A great deal of international research is currently being directed
at developing regenerative medicine using pluripotent stem cells.
Until now, however, little attention has been paid to developing
methods to detect undifferentiated cells in pluripotent stem cell-
based products. Here, we have revealed that a qRT-PCR method
targeting Lin28 can effectively detect a trace amount of hiPSCs in
hiPSC-induced RPE cells and shows potential as an in vitro
tumorigenecity assay of hiPSC-derived cells. We expect our
findings to contribute to the process of validation and quality
control of hiPSCs-based cell therapy products and to promote the
application of regenerative medicine in the treatment of a wide
variety of diseases in the near future.
Materials and Methods
Cell culture
HiPSC line 201B7 induced by transducing Oct3/4, Sox2, Klf4
and c-Myc [2] was obtained from the RIKEN Cell Bank.
Undifferentiated hiPSCs were maintained on mitomycin C-treated
SNL cells (a mouse fibroblast STO cell line expressing the
neomycin-resistance gene cassette and LIF) in human ES cell
culture medium (ReproCell, Japan) supplemented with 4 ng/ml
human basic fibroblast growth factor (bFGF; WAKO, Japan).
Undifferentiated colonies were passaged as small clumps once in
every 5–6 days using CTK solution (ReproCell) and STEMPRO
EZPassage (Invitrogen, Carlsbad, CA). Human primary RPE cells
were obtained from the Lonza and ScienCell Research Labora-
tories. The primary RPE cells were maintained in Retinal Pigment
Epithelial Cell Basal Medium (Lonza Biologics, Basel, Switzerland)
containing supplements (L-glutamine, GA-1000 and bFGF;
Lonza). PA-1 cells derived from human ovarian teratocarcinoma
(ATCC, Manassas, VA) were maintained on Minimum Essential
Medium Eagle medium (Sigma–Aldrich, St. Louis) supplemented
with 10% (v/v) fetal bovine serum (FBS; Gibco, Paisley, UK). All
cell lines and differentiated cells were grown in a humidified
atmosphere of 5% CO2 and 95% air at 37uC.
RPE cell differentiation of hiPSCs
The procedure for differentiating hiPSCs into RPE cells was
performed according to the previously described protocol [7] as
shown in Figure 1A. The hiPSC clumps were first incubated on
Figure 2. Soft agar colony formation assay of hiPSCs and
teratocarcinoma PA-1 cells. (A) Phase-contrast images of hiPSCs,
primary RPE cells, hiPSC-derived RPE cells and PA-1cells spiked into
primary RPE cells (1%) cultured in soft agar medium for 30 days. Arrows
indicate the colonies of PA-1 cells. (B) PA-1 cells (1%, 100 cells; 0.5%, 50
cells; 0.25%, 25 cells; 0%, 0 cells) were spiked into 1.0610
4 primary RPE
cells and grown in soft agar for 10, 20 and 30 days. Cell growth was
quantified using a CytoSelect kit. Results were expressed as a relative
fold change of the value of blank well. Statistical significance was
determined using two-way ANOVA and Bonferroni’s post-hoc test
(*P,0.05 compared with the 0% control). (C) HiPSC-derived RPE cells,
three lots of primary RPE cells and PA-1 cells spiked into primary RPE
cells were grown in soft agar for 30 days. Quantification of the results is
described in (B). Limit of detection was calculated as the mean plus 3.3
fold the standard deviation of the measurement of the three lots of
primary RPE cells. Error bars represent the standard deviation of the
measurements (n=3).
doi:10.1371/journal.pone.0037342.g002
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(red). Cells were fixed, permiabilized and stained with anti-TRA-1-60, anti-TRA-1-81, anti-Sox2, anti-Oct3/4 and anti-Nanog antibodies labeled with
fluorophore. (B) Five lots of primary RPE cells were analyzed by flow cytometry with anti-TRA-1-60 antibody. (C) HiPSCs (0.1%, 2.5610
2 cells; 0.01%, 25
cells) were spiked into primary RPE cells (2.5610
5 cells) and analyzed by flow cytometry with anti-TRA-1-60 antibody. (D) Flow cytometry analysis of
hiPSC-derived RPE cells was performed with anti-TRA-1-60 antibody. Ten thousand cells (A) and 1610
5 cells (B–D) were used for one assay of flow
cytometry analysis. The numbers indicate the quantity of cells contained in the gate.
doi:10.1371/journal.pone.0037342.g003
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medium supplemented with 10 mM Y-27632 (WAKO), 5 mM
SB431542 (Sigma–Aldrich) and 3 mM CKI-7 (Sigma–Aldrich) for
1 day. The cells were incubated in a differentiation medium
(Glasgow minimum essential medium [GMEM; Invitrogen],
0.1 mM non-essential amino acids, 1 mM sodium pyruvate, and
0.1 mM 2-mercaptoethanol) containing 20% knockout serum
replacement (KSR; Invitrogen) for 4 days, then in 15% KSR-
containing differentiation medium for 6 days, and finally in 10%
KSR-containing differentiation medium for 11–30 days. Y-27632
(10 mM), SB431542 (5 mM) and CKI-7 (3 mM) were added to the
differentiation medium for the first 13, 19 and 19 days,
respectively. Partially differentiated cells were dissociated with
the CTK solution and incubated on non-adhesive dishes (Corning,
Corning, NY) in RPE maintenance medium (DMEM:F12 [7:3]
supplemented with B-27 supplement [Invitrogen] and 2 mM L-
glutamine [Invitrogen]) for 10 days. The resulting RPE cell
aggregates were isolated and replated on CELLstart- (Invitrogen)
coated dishes in RPE maintenance medium supplemented with
0.5 mM SB431542 and 10 ng/ml bFGF and we defined this stage
as passage 1. The medium was changed every 2–3 days.
Soft agar colony formation assay
A soft agar colony formation assay was performed using
CytoSelect 96-well Cell Transformation Assay kit (Cell Biolabs,
San Diego, CA) according to the manufacturer’s instructions with
slight modification. Prewarmed 25 mlo f2 6DMEM medium
containing 20% FBS and 25 ml of 1.2% agar solution were mixed
and transferred onto a well of 96-well plates, and then incubated at
4uC for 30 min to allow the bottom agar layer to solidify. Single
cell suspensions were prepared as described below: 201B7 cells
were dissociated with CTK solution to form cell clumps and
incubated on gelatin-coated dishes in the presence of 10 mMY -
27632, a ROCK inhibitor, at 37uC for 1 h to separate with feeder
cells. After centrifugation, cell pellets were dissociated into single
cells with Accutase (Millipore). Primary RPE cells, hiPSC-derived
RPE cells, and PA-1 cells were treated with 0.25% trypsin-EDTA
solution (Invitrogen) to dissociate. Cells were passed through
40 mm nylon cell strainers (BD Falcon).
Next, 25 ml of single cell suspensions containing the defined
number of cells were mixed with 25 mlo f2 6DMEM medium
containing 20% FBS and 25 ml of 1.2% agar, and placed on the
bottom agar layer. The top agar layers were immediately solidified
at 4uC for 10 min to avoid false-positive signals derived from
gravity-induced adjacent cells in the agar medium. After the
addition of 100 ml of DMEM containing 10% FBS to each well,
the plates were incubate for 10, 20 and 30 days at 37uC and 5%
CO2. The medium was changed every 2–3 days. Colonies were
lysed and quantified with CyQuant GR dye using a fluorometer
equipped with a 485/520 nm filter set (Wallac 1420 ARVOsx
mutilabel counter, PerkinElmer, Boston, MA).
Figure 4. Detection of undifferentiated hiPSCs by qRT-PCR
assay. (A) The relative mRNA expressions in primary RPE cells of Lin28,
Oct-3/4, Sox2, Nanog, Rex1, Klf4, and c-Myc were determined by qRT-
PCR analysis. (B–D) qRT-PCR analysis of hiPSCs spiked into primary RPE
cells and five lots of primary RPE cells. Single-cell hiPSCs (1%, 2.5610
3
cells; 0.1%, 2.5610
2 cells; 0.01%, 25 cells) were spiked into 2.5610
5
primary RPE cells, and total RNA was isolated from the mixed cells. The
mRNA levels of Nanog (B), Oct3/4 (C) and Lin28 (D) are shown as a
relative expression. Limit of detection was calculated as the mean plus
3.3 fold the standard deviation of the measurement of the five lots of
primary RPE cells. (E) Lin28 expression of hiPSCs differentiating into RPE
and purified hiPSC-derived RPE cells (passage 3 and 4). All values are
expressed as mRNA levels relative to those in undifferentiated hiPSCs.
Results are means 6 standard deviation (n=3).
doi:10.1371/journal.pone.0037342.g004
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Total RNA was isolated from cell cultures using an RNeasy
Mini Kit (Qiagen, Hilden, Germany) and treated with DNase I
according to the manufacturer’s instructions. In the spike study,
201B7 cells and RPE cells were mixed at a defined cell number,
before total RNA isolation. qRT-PCR was performed with the
QuantiTect Probe one-step RT-PCR Kit (Qiagen) on a 7300
Real-Time PCR System (Applied Biosystems, Foster City, CA).
The expression levels of target genes were normalized to those of
the GAPDH (glyceraldehyde-3-phosphate dehydrogenase) tran-
script, which were quantified using TaqMan human GAPDH
control reagents (Applied Biosystems). Probes and primers were
obtained from Sigma–Aldrich. The sequences of primers and
probes used in the present study are listed in Table S1. All qRT-
PCR reactions were run at 45 cycles.
Flow Cytometry
201B7 cells and RPE cells were dissociated into single cells as
described above. Cells were fixed with the BD Cytofix fixation
buffer (BD Biosciences, Bedford, MA) for 20 min and permeabi-
lized with BD Perm/Wash buffer (BD Biosciences) for 10 min at
room temperature. Cells were incubated for 1 h at room
temperature with the following primary antibodies and fluoro-
chrome-conjugated antibodies: mouse anti-CRALBP monoclonal
1:1000 (B2, Thermo Scientific, Roskilde, Denmark); rabbit anti-
GP-100 monoclonal 1:1000 (P14-V, Enzo Life Sciences, Lausen,
Switzerland); FITC mouse anti-TRA-1-60 monoclonal 1:5 (TRA-
1-60, BD Pharmingen); PE mouse anti-TRA-1-81 monoclonal 1:5
(TRA-1-81, BD Pharmingen); PerCP-Cy5.5 mouse anti-Oct3/4
monoclonal 1:5 (40/Oct-3, BD Pharmingen); Alexa Fluor 647
mouse anti-Sox2 monoclonal 1:5 (245610, BD Pharmingen); PE
mouse anti-Nanog monoclonal 1:5 (N31–355, BD Pharmingen).
Indirect immunostaining was then completed with either donkey-
anti-mouse or donkey-anti-rabbit Alexa Fluor 647-conjugated
secondary antibodies 1:1000 (Molecular Probes) for 1 h. Appro-
priate antibodies were used as a negative control. To obtain
fluorescein-labeled hiPSCs, 201B7 cells were incubated with
10 mM carboxyfluorescein diacetate succinimidyl ester (CFDA;
Invitrogen) in phosphate buffered saline (PBS) for 8 min,
dissociated into a single cell suspension, and then fixed as
described above. Stained cells were analyzed with a BD FACSAria
II (BD Biosciences). Data retrieved from the sorting was analyzed
with Flowjo software 9.3.3 (Tree Star, Ashland, OR).
Immunocytochemistry
All manipulations were performed at room temperature.
Cultured primary and hiPSC-derived RPE cells were fixed with
4% paraformaldehyde in PBS for 20 min at room temperature.
After washing with PBS, the cells were permeabilized with 0.2%
Triton-X100 in PBS for 15 min and blocked with 2% bovine
serum albumin in PBS for 30 min. Samples were incubated for 1 h
with mouse anti-N-cadherin monoclonal antibody 1:1000 (GC-4,
Sigma–Aldrich). The cells were washed with PBS and incubated
with 1:1000 Alexa Fluor 488 F(ab9)2 fragment of goat anti-mouse
IgG 1:1000 (Molecular Probes) for 1 h. The samples were
mounted with a Vectashield mounting medium containing DAPI
(Vector Laboratories, Burlingame, CA) and examined with a
Biozero-8000 fluorescence microscope (Keyence, Japan).
Supporting Information
Figure S1 Soft agar colony formation assay of hiPSCs,
teratocarcinoma PA-1 cells and primary RPE cells. (A)
hiPSCs (10000 cells, 6000cells and 3000 cells/well) were grown in
soft agar for 10, 20 and 30 days with 10 mM Y-27632. (B) PA-1
cells (1000, 500, 300, 200, 100, 50, 30 cells/well) were grown in
soft agar for 20 days. (C) Primary RPE cells (lot. A, 100,000,
60,000, 30,000 and 10,000 cells/well) were grown in soft agar for
30 days. (A–C) Cell growth was quantified using a CytoSelect kit
and the results expressed as a relative fold change of the value of a
blank well. Error bars represent the standard deviation of the
measurements (n=3).
(EPS)
Table 1. Comparison of the tumorigenicity-associated assays.
Assay
Soft agar colony
formation assay Flow cytometry qRT-PCR
In vivo tumorigenicity assay using
SCID mice (Reference #11)
Measurement standard Colony formation Expression of marker
protein for pluripotency
Expression of marker gene for
pluripotency
Tumor formation
Purpose Detection of anchorage
independent growth
Detection of undifferentiated
pluripotent cells
Detection of undifferentiated
pluripotent cells
Detection of tumorigenic or
undifferentiated pluripotent cells
Time 30 days 1 day 6 hours 12–16 weeks
Advantage Inexpensive Rapid Rapid and simple Direct
Analyzing individual cells Quantitative Analyzing tumor formation in a
specific microenvironment
High sensitivity
Disadvantage Indirect Indirect Indirect Costly
Not applicable to hiPSCs Detecting only the cells that
express the known maker
molecules
Detecting only the cells that express
the known marker genes
Time-consuming
Gating techniques strongly
influence the result
LLOD 1% of PA-1 0.1% of hiPSC (TRA-1-60) =,0.002% of hiPSC* (Lin28) 245 undifferentiated hESCs with 10
6
feeder fibroblasts (0.025%)
*Not based on the calculation found in Reference #21 because the background signal from the negative controls (primary RPE cells) was not detectable.
doi:10.1371/journal.pone.0037342.t001
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cells in primary RPE. CFDA-stained hiPSCs (1%, 2,500 cells;
0.1%, 250 cells; 0.01%, 25 cells) were spiked into primary RPE
(2.5610
5 cells) and 1610
5 cells were analyzed by flow cytometry.
The numbers indicate the quantity of cells contained in the gate.
(EPS)
Table S1 Probes and primers for qRT-PCR.
(DOCX)
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